Company / EPS (Diluted)
FILANA THERAPEUTICS, INC. EPS (Diluted) History
FY2011-FY2015 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$0.70
FY2015
5-year range
-$0.28 / $0.70
FY2011-FY2015
Trend
+975.0%
vs FY2014
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) changed +975% YoY in FY2015, a notable deviation from the 4-year average annual change of +193%.
Based on SEC 10-K filings.
0.70 in FY2015.
Improved from $-0.06 to $0.70 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2015, eps (diluted) increased 975.0% year-over-year.
- Lowest eps (diluted) in the period was in FY2012.
Company context
Key Data Points
- Altman Z-Score 3.76 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2015 | $0.70 | +975.0% |
| FY2014 | -$0.08 | -33.3% |
| FY2013 | -$0.06 | +78.6% |
| FY2012 | -$0.28 | -250.0% |
| FY2011 | -$0.08 | - |
As of FY2015 · SEC 10-K · Updated Jun 24, 2026